Cephalexin
Product Images NDC 59834-203

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 59834-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Orchidpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mjbivjb (Cephalexin For Oral Figure 1)

Chemical structure diagram of cephalexin monohydrate, showing its beta-lactam core with attached amino and thiazolidine rings, phenyl group, and associated hydrogen atoms, including a water molecule (H2O).*

FDA Label Image

Lab1 (Cephalexin For Oral Figure 2)

Cephalexin for Oral Suspension, USP 125 mg/5 mL in a 100 mL (when mixed) container, labeled by OrchidPharma Inc. The label indicates prescription-only status and displays the NDC 59834-202-17.*

FDA Label Image

Lab2 (Cephalexin For Oral Figure 3)

Label for Cephalexin for Oral Suspension USP, 250 mg/5 mL, manufactured by OrchidPharma Inc. The label indicates the product is prescription only and the final suspension volume is 100 mL when mixed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.